GOOD Meat Leads the Cultivated Meat Industry Toward Price Parity with Regulatory Approval of its Serum-Free Media in Singapore
CULT Food Science announced that its affiliate, GOOD Meat, has gained the world's first regulatory approval from the Singapore Food Agency (SFA) for serum-free media in cultivated meat production. This milestone aims to lower costs and enhance scalability, bringing the industry closer to competing with traditional meat prices. Currently, growth media accounts for up to 95% of cultivated meat production costs, making this approval significant. GOOD Meat also launched cultivated meat sales at Huber's Butchery in Singapore and is constructing a facility to produce large quantities using the new serum-free process, expected to open later in 2023.
- Regulatory approval for serum-free media may significantly reduce production costs.
- GOOD Meat is advancing towards price parity with conventional meat.
- New facility in Singapore is set to produce large quantities of cultivated meat, enhancing scalability.
- None.
Insights
Analyzing...
Cellular agriculture technology traditionally uses Fetal Bovine Serum (FBS) in bioreactors as an effective growth medium to cultivate animal cells into the muscle, fat, and connective tissues that form meat. However,
GOOD Meat's approval for the use of serum-free media will make cultivated meat production more scalable and efficient, inching the industry closer to price parity, in comparison to conventional animal agriculture.
GOOD Meat recently launched at Huber's Butchery in
Management Commentary
"This announcement from GOOD Meat is another example of their leadership in the cellular agriculture industry. Access for the industry at large to low cost cell culture media, with consistent quality, is a key element to the industries long term success. It can make the difference if the end product for consumers is affordable and accessible, or not" said Lejjy Gafour, CEO of CULT.
About
Eat Just is a food technology company with a mission to build a healthier, safer and more sustainable food system in our lifetimes. The company's expertise, from functionalizing plant proteins to culturing animal cells, is powered by a world-class team of scientists and chefs spanning more than a dozen research disciplines. Eat Just created one of America's fastest-growing egg brands, which is made entirely of plants, and the world's first-to-market meat made from animal cells instead of slaughtered livestock. The company has been recognized as one of Fast Company's "Most Innovative Companies," Entrepreneur's "100 Brilliant Companies," CNBC's "Disruptor 50" and a World Economic Forum Technology Pioneer. JUST Egg has been named among Popular Science's "100 Greatest Innovations" and Fast Company's "World Changing Ideas" and the history-making debut of GOOD Meat was heralded as one of 2020's top scientific breakthroughs by The Guardian, Vox and WIRED.
For more information on GOOD Meat, visit goodmeat.co/newsroom. About
Additional information can be found by viewing the Company's website at cultfoodscience.com or its regulatory filings on sedar.com.
On behalf of the Board of Directors of the Company,
"Lejjy Gafour"
Lejjy Gafour, Chief Executive Officer
Web: CULTFoodScience.com
Information set forth in this news release may involve forward-looking statements. Forward-looking statements are statements that relate to future, not past, events. In this context, forward-looking statements often address a company's expected future business and financial performance, and often contain words such as "anticipate", "believe", "plan", "estimate", "expect", and "intend", statements that an action or event "may", "might", "could", "should", or "will" be taken or occur, or other similar expressions. By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements, or other future events, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include but are not limited to the following risks: those associated with marketing and sale of securities; the need for additional financing; reliance on key personnel; the potential for conflicts of interest among certain officers or directors with certain other projects; and the volatility of common share price and volume. Forward-looking statements are made based on management's beliefs, estimates and opinions on the date that statements are made and except as required by law, the Company undertakes no obligation to update forward-looking statements if these beliefs, estimates and opinions or other circumstances should change. Investors are cautioned against attributing undue certainty to forward-looking statements. For further information on risk, investors are advised to see the Company's MD&A and other disclosure filings with the regulators which are found at sedar.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/good-meat-leads-the-cultivated-meat-industry-toward-price-parity-with-regulatory-approval-of-its-serum-free-media-in-singapore-301727656.html
SOURCE